Clinical Trial Update: Study of Hepatocyte Growth Factor (HGF) Via Plasmid Vector to Improve Perfusion in Critical Limb Ischemia Patients With Peripheral Ischemic Ulcers [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating hepatocyte growth factor via plasmid vector to improve perfusion in critical limb ischemia with peripheral ischemic ulcers; trial compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arterial Occlusive Disease
• Critical Limb Ischemia
• Ischemia
• Peripheral Vascular Disease
• Peripheral Vascular Ulcers

Drugs mentioned

• HGF plasmid vector (gene therapy approach) (hepatocyte growth factor plasmid)

Snippet

Sponsor: AnGes USA, Inc. | Conditions: Arterial Occlusive Disease, Peripheral Vascular Disease | Phase 2 | Status: COMPLETED | Results posted: 2011-08-19